-

Viz.ai Wins Comparably Awards for Best Place to Work for Third Consecutive Year

Healthcare AI leader recognized for its outlook, leadership and career growth

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, has been named a Best Place to Work by Comparably, a leading workplace culture and compensation monitoring employee review platform, for three consecutive years. The Company received three Comparably Best Place to Work Awards in 2024 for Best Company Outlook, Best Leadership Teams and Best Career Growth.

"We are thrilled that Viz.ai has been recognized with three distinguished awards for our exceptional workplace culture. These accolades reflect the dedication and hard work of our team as well as our unwavering commitment to expanding access to life-saving treatments," said Dawn Sprague, vice president of People at Viz.ai. "Our primary goal is to cultivate an environment where everyone can thrive and develop, and we remain dedicated to investing in a culture that supports each individual's ambitions and personal growth."

Viz.ai ranks in the top 5% of other companies on Comparably with 201-500 employees for overall company culture. Out of 492 Viz.ai employee reviews, 93% were positive. In an anonymous survey, one Viz.ai team member shared, “Viz provides a dynamic and empowering work environment. The flexibility with work hours and wellness days foster a healthy work-life balance, and the remote structure encourages autonomy. Overall, it's been an enriching experience that values individual contributions while promoting adaptability.”

Comparably recognizes exceptional companies with the Best Place to Work Awards based on anonymous employee ratings about their workplaces over a 12-month period. The final data set was compiled from over 20 million ratings across 70,000 companies.

To learn about opportunities to join Viz.ai, please visit https://www.viz.ai/careers.

About Viz.ai

Viz.ai is the pioneer in the use of AI algorithms and machine learning to increase the speed of diagnosis and care across 1,600+ hospitals and health systems in the U.S. and Europe. The AI-powered Viz.ai OneTM is an intelligent care coordination solution that identifies more patients with a suspected disease, informs critical decisions at the point of care, and optimizes care pathways and helps improve outcomes. Backed by real-world clinical evidence, Viz.ai One delivers significant value to patients, providers, and pharmaceutical and medical device companies. For more information visit viz.ai.

Contacts

Media
Olivia Schlabach
olivia.schlabach@finnpartners.com

Viz.ai


Release Versions

Contacts

Media
Olivia Schlabach
olivia.schlabach@finnpartners.com

Social Media Profiles
More News From Viz.ai

Viz.ai and Salesforce Collaborate to Transform Pharma Engagement With Real-Time Clinical Intelligence for Agentforce

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the launch of a new real-time clinical intelligence service for Salesforce’s Agentforce Life Sciences. These services will power new and existing agentic solutions for life sciences customers, including a data integration that will bring Viz.ai’s real-time data, triggers, and clinical intelligence layer from across a network of nearly 2,000 hospitals covering 230...

Viz.ai Closes 2025 with Record Scale and Patient Impact, Achieving Profitability in Its Healthcare Business while Accelerating Life Sciences Growth

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a milestone year marked by record growth in its provider footprint, profitability across its healthcare business, the launch of Viz Oncology and Viz Assist, and the doubling of its life sciences business over the past 18 months. Viz.ai is now adopted in nearly 2,000 hospitals across the United States, including the majority of the 50 largest health systems, suppo...

Viz.ai and NCCN Collaborate to Integrate NCCN Guidelines into Clinical Workflows for Oncologists

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced an agreement with the National Comprehensive Cancer Network® (NCCN®). This collaboration integrates NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Breast, Prostate, and Bladder Cancer into the Viz Oncology Platform making this important information readily available to clinicians when they’re making critical decisions about patient care. Thr...
Back to Newsroom